All articles by Clare Sansom – Page 3
-
FeaturePeople power
Harnessing the wisdom – and money – of crowds has rocketed in popularity in recent years. Clare Sansom looks at whether chemistry can join the gang
-
FeatureThe latent threat of tuberculosis
Although TB was close to being eradicated in the developed world, it is a major problem in developing countries. With drug-resistant strains on the increase, Clare Sansom outlines the latest in the fight against this killer disease
-
Feature
Climbing the data mountain
Clare Sansom takes a 'peak' at the databases that stop researchers being buried under an avalanche of chemical information
-
FeatureTurning the tables on Alzheimer's
As our understanding of Alzheimer's disease develops, Clare Sansom takes a look at emerging strategies for treating this enigmatic illness
-
Feature
Fighting the flu
The threat of pandemic influenza is constantly on the horizon. Clare Sansom explores the latest attempts to tackle an ever-changing foe
-
FeatureReceptive receptors
One route to developing new drugs is to look at targeting the hundreds of G-protein-coupled receptors that are not currently exploited clinically. Clare Sansom investigates
-
Feature
Model molecules
As computational chemistry's footprint expands, Clare Sansom considers the technical challenges that remain
-
FeatureMolecules made to measure
HIV protease inhibitors have been one of the big successes of rational drug design. Clare Sansom looks at the impact of structural biology on drug discovery
-
Feature
Temozolomide - birth of a blockbuster
The history of anticancer drug temozolomide can be traced back over 30 years - and it all started with some novel nitrogen chemistry, says Clare Sansom
-
Feature
Structuring Europe
Not every country in Europe can afford a synchrotron. So as new member states join, how is EU funding getting the best out of research across the continent? Clare Sansom reports
- Previous Page
- Page1
- Page2
- Page3
- Next Page